Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches

Department of Cell and Molecular Biology ,Faculty of Biological Sciences ,Kharazmi University ,Tehran ,Iran
Zareei, Sara;
Department of Chemical Engineering ,Faculty of Chemical and Petroleum Engineering ,University of Tabriz ,Tabriz ,Iran
Pourmand, Saeed;
Department of Medicinal Chemistry ,Faculty of Pharmacy ,Tehran University of Medical Sciences ,Tehran ,Iran
Amanlou, Massoud

The SARS-CoV-2, the virus which is responsible for COVID-19 disease, employs its spike protein to recognize its receptor, angiotensin-converting enzyme 2 (ACE2), and subsequently enters the host cell. In this process, the receptor-binding domain (RBD) of the spike has an interface with the α1-helix of the peptidase domain (PD) of ACE2. This study focuses on the disruption of the protein-protein interaction (PPI) of RBD-ACE2. Among the residues in the template (which was extracted from the ACE2), those with unfavorable energies were selected for substitution by mutagenesis. As a result, a library of 140 peptide candidates was constructed and the binding affinity of each candidate was evaluated by molecular docking and molecular dynamics simulations against the α1-helix of ACE2. Finally, the most potent peptides P23 (GFNNYFPHQSYGFMPTNGVGY), P28 (GFNQYFPHQSYGFPPTNGVGY), and P31 (GFNRYFPHQSYGFCPTNGVGY) were selected and their dynamic behaviors were studied. The results showed peptide inhibitors increased the radius, surface accessible area, and overall mobility of residues of the protein. However, no significant alteration was seen in the key residues in the active site. Meanwhile, they can be proposed as promising agents against COVID-19 by suppressing the viral attachment and curbing the infection at its early stage. The designed peptides showed potency against beta, gamma, delta, and omicron variants of SARS-CoV-2.


Citation style:
Could not load citation form.

Access Statistic

Last 12 Month:


License Holder: Copyright © 2022 Zareei, Pourmand and Amanlou.

Use and reproduction: